Comparative Effectiveness Of Budesonide/formoterol Combination (bfc) And Tiotropium Bromide Among Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment

被引：0
|
作者：
Strange, C. B. [1 ]
Racketa, J. [2 ]
Kern, D. M. [3 ]
Williams, S. A. [2 ]
Tunceli, O. [3 ]
Zhou, S. [3 ]
Graham, E. [4 ]
Trudo, F. [2 ]
机构：
[1] Med Univ South Carolina, Charleston, SC USA
[2] AstraZeneca, Wilmington, DE USA
[3] HealthCore Inc, Wilmington, DE USA
[4] AstraZeneca, Alderley Pk, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3725
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evaluating Characteristics Of Chronic Obstructive Pulmonary Disease (COPD) Patients New To Controller Treatment: Budesonide/formoterol Combination (bfc) Versus Tiotropium
    Williams, S.
    Trudo, F.
    Kern, D.
    Wessman, C.
    Tunceli, O.
    Zhou, S.
    Pethick, N.
    Elhefni, H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [2] Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
    Trudo, Frank
    Kern, David M.
    Davis, Jill R.
    Tunceli, Ozgur
    Zhou, Siting
    Graham, Emma L.
    Strange, Charlie
    Williams, Setareh A.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2055 - 2066
  • [3] Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease
    Feng, Jun-fei
    Ding, Guo-rong
    Xie, Yan-zhong
    Zhao, Dejun
    Wang, Xuehui
    [J]. MEDICINE, 2018, 97 (22)
  • [4] Erratum to: Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease
    Nicole Mittmann
    Paul Hernandez
    Carl Mellström
    Lance Brannman
    Tobias Welte
    [J]. PharmacoEconomics, 2011, 29 : 414 - 414
  • [5] Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study
    David M Kern
    Jill Davis
    Setareh A Williams
    Ozgur Tunceli
    Bingcao Wu
    Sally Hollis
    Charlie Strange
    Frank Trudo
    [J]. Respiratory Research, 16
  • [6] Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study
    Kern, David M.
    Davis, Jill
    Williams, Setareh A.
    Tunceli, Ozgur
    Wu, Bingcao
    Hollis, Sally
    Strange, Charlie
    Trudo, Frank
    [J]. RESPIRATORY RESEARCH, 2015, 16
  • [7] The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease
    Um, Sang-Won
    Yoo, Chul-Gyu
    Kim, Young Whan
    Han, Sung Koo
    Shim, Young-Soo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (05) : 839 - 845
  • [8] Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease
    Centanni, S
    Di Marco, F
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (14) : 2525 - 2534
  • [9] Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease
    Zhao, Daguo
    Ling, Chunhua
    Guo, Qiang
    Jin, Jun
    Xu, Hua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (06) : 4578 - 4584
  • [10] Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease
    Jayanthi, Nalini
    Krishnan, Karthickeyan
    Sudhir, Manali
    Girija, S.
    Nishi, P. A.
    Kumar, J. Sathish
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 28
12345